Transcriptional profiling of whole blood identifies a unique 5-gene signature for myelofibrosis and imminent myelofibrosis transformation

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Hasselbalch, Hans Carl ^a   Skov, Vibe ^b   Larsen, Thomas Stauffer ^b   Thomassen, Mads ^b   Riley, Caroline Hasselbalch ^a   Jensen, Morten K ^a   Bjerrum, Ole Weis ^a   Kruse, Torben A ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; JANUS KINASE 2;

ARTICLE; AZUROCIDIN 1 GENE; CATHEPSIN G GENE; CLUSTER ANALYSIS; CONTROLLED STUDY; DEFENSIN ALPHA 4 GENE; ELASTASE 2 NEUTROPHIL GENE; GENE; GENE EXPRESSION; GENE MUTATION; HUMAN; JAK2 GENE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MONOCYTE COUNT; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE NEOPLASM; NEUTROPHIL COUNT; OLFACTOMEDIN 4 GENE; POLYCYTHEMIA VERA; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; UPREGULATION;

CASE-CONTROL STUDIES; CLUSTER ANALYSIS; DISEASE PROGRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; POLYCYTHEMIA VERA; PRIMARY MYELOFIBROSIS; THROMBOCYTHEMIA, ESSENTIAL;

EID: 84897999475     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085567     Document Type: Article

References (38)

1. Campbell PJ, Green AR (2006) The myeloproliferative disorders. N Engl J Med 55: 2452-66. (Pubitemid 44903749)
2. Tefferi A (2000) Myelofibrosis with myeloid metaplasia. N Engl J Med 342 (17): 1255-1265.
3. Barosi G, Viarengo G, Pecci A, Rosti V, Piaggio G, et al. (2001) Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia. Blood 98(12): 3249-3255.
4. Puigdecanet E, Espinet B, Lozano JJ, Sumoy L, Bellosillo B, et al. (2008) Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia. Leukemia 22:1368-1376.
5. Pellagatti A, Vetrie D, Langford CF, Gama S, Eagleton H, et al. (2003) Gene expression profiling in polycythemia vera using cDNA microarray technology. Cancer Res 63: 3940-3944. (Pubitemid 36917909)
6. Guglielmelli P, Zini R, Bogani C, Salati S, Pancrazzi A, et al. (2007) Molecular profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of Wilms' tumor gene 1 (WT1). Stem Cells 25:165-173. (Pubitemid 46052987)
7. Kralovics R, Teo SS, Buser AS, Brutsche M, Tiedt R, et al. (2005) Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2. Blood 106: 3374-3376. (Pubitemid 41609168)
8. Jones LC, Tefferi A, Vuong PT, Desmond JC, Hofmann WK, et al. (2005) Detection of aberrant gene expression in CD34+ hematopoietic stem cells from patients with agnogenic myeloid metaplasia using oligonucleotide microarrays. Stem Cells 23:631-637. (Pubitemid 40647259)
9. Catani L, Zini R, Sollazzo D, Ottaviani E, Vannucchi AM, et al. (2009) Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia. Leukemia 23: 997-1000.
10. Gnatenko DV, Zhu W, Xu X, Samuel ET, Monaghan M, et al. (2010) Class prediction models of thrombocytosis using genetic biomarkers. Blood 115: 7-14.
11. Berkofsky-Fessler W, Buzzai M, Kim MK, Fruchtman S, Najfeld V, et al. (2010) Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F. Clin Cancer Res 16: 4339-4352.
12. Hasselbalch HC, Skov V, Larsen TS, Thomassen M, Riley CH, et al. (2011) High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis. Leuk Res 35(10): 1330-1334.
13. Skov V, Larsen TS, Thomassen M, Riley CH, Jensen MK, et al. (2012) Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms. Leuk Lymphoma 53(1): 123-129.
14. Skov V, Larsen TS, Thomassen M, Riley, Jensen MK, et al. (2011) Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis. Eur J Haematol 87: 54-60.
15. Skov V, Thomassen M, Riley CH, Jensen MK, Bjerrum OW, et al. (2012) Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis. Exp Hematol 40(9): 771-780.
16. Skov V, Larsen TS, Thomassen M, Riley CH, Jensen MK, et al. (2012) Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance. Leuk Res 36(11): 1387-1392.
17. Ihaka R, Gentleman R (1996) R: a language for data analysis and graphics. J Comp Graph Stat 5: 299-314.
18. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
19. Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: 1-25 (article 3).
20. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57: 289-300.
21. Borregaard N, Cowland JB (1997) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89: 3503-3521. (Pubitemid 27227073)
22. Borregaard N, Theilgaard-Monch K, Sorensen OE, Cowland JB (2001) Regulation of human neutrophil granule protein expression. Curr Opin Hematol 8: 23-27. (Pubitemid 32047658)
23. Theilgaard-Monch K, Jacobsen LC, Borup R, Rasmussen T, Bjerregaard MD, et al. (2005) The transcriptional program of terminal granulocytic differentiation. Blood 105: 1785-1796. (Pubitemid 40223703)
24. Hager M, Cowland JB, Borregaard N (2010) Neutrophil granules in health and disease. J Intern Med 268: 25-34.
25. Xu M, Bruno E, Chao J, Huang S, Finazzi G, et al. (2005) Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases. Blood 105(11): 4805-4815.
26. Lataillade JJ, Pierre-Louis O, Hasselbalch HC, Uzan G, Jasmin C, et al. (2008) French INSERM and the European EUMNET Networks on Myelofibrosis. Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence. Blood 112(8): 3026-3035.
27. Hasselbalch HC (2009) Myelofibrosis with myeloid metaplasia: the advanced phase of an untreated disseminated hematological cancer. Time to change our therapeutic attitude with early upfront treatment? Leuk Res 33(1): 11-18.
28. Passamonti F, Rumi E, Pietra D, Della Porta MG, Boveri E, et al. (2006) Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34 + cells into peripheral blood in myeloproliferative disorders. Blood 107(9): 3676-3682.
29. Grover PK, Hardingham JE, Cummins AG (2010) Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis. Cancer Metastasis Rev 4: 761-75.
30. Yu L, Wang L, Chen S (2011) Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers. Neoplasma 58(1): 9-13.
31. Liu W, Lee HW, Liu Y, Wang R, Rodgers GP (2010) Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-29-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis. Blood 116(23): 4938-4947.
32. Clemmensen SN, Bohr CT, Rørvig S, Glenthøj A, Mora-Jensen H, et al. (2012) Olfactomedin 4 defines a subset of human neutrophils. J Leukoc Biol 91(3): 495-500.
33. Dar A, Kollet O, Lapidot T (2006) Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 34: 967-975. (Pubitemid 44080383)
34. Rosti V, Massa M, Vannucchi AM, Bergamaschi G, Campanelli R, et al. (2007) The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia. Blood Cells Mol Dis 38(3): 280-286. (Pubitemid 46518174)
35. Hasselbalch HC (2012) Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood 119(14): 3219-25.
36. Hasselbalch HC (2013) Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development? Leuk Res 37(2): 214-20.
37. Hasselbalch HC (2013) The role of cytokines in the initiation and progression of myelofibrosis. Cytokine Growth Factor Rev 24(2): 133-45.
38. Hasselbalch HC (2013) A role of NF-E2 of chronic inflammation and clonal evolution in essential thrombocythemia, polycythemia vera and myelofibrosis? Leuk Res Aug 8.